CINGAL Phase III Data Demonstrates Efficacy and Safety to Treat Knee OA Pain
Phase III study results demonstrated that Anika Therapeutics’ CINGAL® provided superior immediate and short term OA pain relief after injection...
Phase III study results demonstrated that Anika Therapeutics’ CINGAL® provided superior immediate and short term OA pain relief after injection...
Integra LifeSciences signed an agreement with aap Implantate to distribute the LOQTEQ® Distal Radius System in the U.S. ...
BONESUPPORT enrolled the first patient in the pivotal IDE trial of CERAMENT G in the surgical repair of open diaphyseal...
Vericel entered into a 2-year renewable agreement with Orsini Pharmaceutical for distribution of Carticel® and MACI® in the U.S. and Puerto Rico. ...
Device companies are prioritizing supply chain alignment to achieve company vision, leverage expertise and obtain significant cost savings. For insight...
Zimmer Biomet entered into an agreement to license patents from Bonutti Research, supporting the development of the Rosa® robotic total knee...
Amend Surgical entered into a funding agreement in support of products for the bone graft substitute market....
Stryker entered into an agreement to distribute AlloSource biologic products in the U.S. for use in sports medicine procedures....
Interim study results indicate that patients receiving Rotation Medical’s Bioinductive Implant to treat rotator cuff disease reported statistically significant improvement...
Globus Medical plans to resubmit its 510(k) for the ExcelsiusGPSâ„¢ system to FDA, and noted that its clearance is now...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.